Sulfonylureas Correct Trafficking Defects of ATP-sensitive Potassium Channels Caused by Mutations in the Sulfonylurea Receptor

Feifei Yan, Chia Wei Lin, Elizabeth Weisiger, Etienne A. Cartier, Grit Taschenberger, Show-Ling Shyng

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

The pancreatic ATP-sensitive potassium (KATP) channel, a complex of four sulfonylurea receptor 1 (SUR1) and four potassium channel Kir6. 2 subunits, regulates insulin secretion by linking metabolic changes to β-cell membrane potential. Sulfonylureas inhibit KATP channel activities by binding to SUR1 and are widely used to treat type II diabetes. We report here that sulfonylureas also function as chemical chaperones to rescue KATP channel trafficking defects caused by two SUR1 mutations, A116P and V187D, identified in patients with congenital hyperinsulinism. Sulfonylureas markedly increased cell surface expression of the A116P and V187D mutants by stabilizing the mutant SUR1 proteins and promoting their maturation. By contrast, diazoxide, a potassium channel opener that also binds SUR1, had no effect on surface expression of either mutant. Importantly, both mutant channels rescued to the cell surface have normal ATP, MgADP, and diazoxide sensitivities, demonstrating that SUR1 harboring either the A116P or the V187D mutation is capable of associating with Kir6.2 to form functional K ATP channels. Thus, sulfonylureas may be used to treat congenital hyperinsulinism caused by certain KATP channel trafficking mutations.

Original languageEnglish (US)
Pages (from-to)11096-11105
Number of pages10
JournalJournal of Biological Chemistry
Volume279
Issue number12
DOIs
StatePublished - Mar 19 2004

Fingerprint

Sulfonylurea Receptors
KATP Channels
Defects
Mutation
Congenital Hyperinsulinism
Diazoxide
Adenosine Triphosphate
Potassium Channels
Cell membranes
Medical problems
Membrane Potentials
Adenosine Diphosphate
Type 2 Diabetes Mellitus
Potassium
Cell Membrane
Insulin

ASJC Scopus subject areas

  • Biochemistry

Cite this

Sulfonylureas Correct Trafficking Defects of ATP-sensitive Potassium Channels Caused by Mutations in the Sulfonylurea Receptor. / Yan, Feifei; Lin, Chia Wei; Weisiger, Elizabeth; Cartier, Etienne A.; Taschenberger, Grit; Shyng, Show-Ling.

In: Journal of Biological Chemistry, Vol. 279, No. 12, 19.03.2004, p. 11096-11105.

Research output: Contribution to journalArticle

Yan, Feifei ; Lin, Chia Wei ; Weisiger, Elizabeth ; Cartier, Etienne A. ; Taschenberger, Grit ; Shyng, Show-Ling. / Sulfonylureas Correct Trafficking Defects of ATP-sensitive Potassium Channels Caused by Mutations in the Sulfonylurea Receptor. In: Journal of Biological Chemistry. 2004 ; Vol. 279, No. 12. pp. 11096-11105.
@article{2e92f64960ae4bedaf1a48c2364a7809,
title = "Sulfonylureas Correct Trafficking Defects of ATP-sensitive Potassium Channels Caused by Mutations in the Sulfonylurea Receptor",
abstract = "The pancreatic ATP-sensitive potassium (KATP) channel, a complex of four sulfonylurea receptor 1 (SUR1) and four potassium channel Kir6. 2 subunits, regulates insulin secretion by linking metabolic changes to β-cell membrane potential. Sulfonylureas inhibit KATP channel activities by binding to SUR1 and are widely used to treat type II diabetes. We report here that sulfonylureas also function as chemical chaperones to rescue KATP channel trafficking defects caused by two SUR1 mutations, A116P and V187D, identified in patients with congenital hyperinsulinism. Sulfonylureas markedly increased cell surface expression of the A116P and V187D mutants by stabilizing the mutant SUR1 proteins and promoting their maturation. By contrast, diazoxide, a potassium channel opener that also binds SUR1, had no effect on surface expression of either mutant. Importantly, both mutant channels rescued to the cell surface have normal ATP, MgADP, and diazoxide sensitivities, demonstrating that SUR1 harboring either the A116P or the V187D mutation is capable of associating with Kir6.2 to form functional K ATP channels. Thus, sulfonylureas may be used to treat congenital hyperinsulinism caused by certain KATP channel trafficking mutations.",
author = "Feifei Yan and Lin, {Chia Wei} and Elizabeth Weisiger and Cartier, {Etienne A.} and Grit Taschenberger and Show-Ling Shyng",
year = "2004",
month = "3",
day = "19",
doi = "10.1074/jbc.M312810200",
language = "English (US)",
volume = "279",
pages = "11096--11105",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Sulfonylureas Correct Trafficking Defects of ATP-sensitive Potassium Channels Caused by Mutations in the Sulfonylurea Receptor

AU - Yan, Feifei

AU - Lin, Chia Wei

AU - Weisiger, Elizabeth

AU - Cartier, Etienne A.

AU - Taschenberger, Grit

AU - Shyng, Show-Ling

PY - 2004/3/19

Y1 - 2004/3/19

N2 - The pancreatic ATP-sensitive potassium (KATP) channel, a complex of four sulfonylurea receptor 1 (SUR1) and four potassium channel Kir6. 2 subunits, regulates insulin secretion by linking metabolic changes to β-cell membrane potential. Sulfonylureas inhibit KATP channel activities by binding to SUR1 and are widely used to treat type II diabetes. We report here that sulfonylureas also function as chemical chaperones to rescue KATP channel trafficking defects caused by two SUR1 mutations, A116P and V187D, identified in patients with congenital hyperinsulinism. Sulfonylureas markedly increased cell surface expression of the A116P and V187D mutants by stabilizing the mutant SUR1 proteins and promoting their maturation. By contrast, diazoxide, a potassium channel opener that also binds SUR1, had no effect on surface expression of either mutant. Importantly, both mutant channels rescued to the cell surface have normal ATP, MgADP, and diazoxide sensitivities, demonstrating that SUR1 harboring either the A116P or the V187D mutation is capable of associating with Kir6.2 to form functional K ATP channels. Thus, sulfonylureas may be used to treat congenital hyperinsulinism caused by certain KATP channel trafficking mutations.

AB - The pancreatic ATP-sensitive potassium (KATP) channel, a complex of four sulfonylurea receptor 1 (SUR1) and four potassium channel Kir6. 2 subunits, regulates insulin secretion by linking metabolic changes to β-cell membrane potential. Sulfonylureas inhibit KATP channel activities by binding to SUR1 and are widely used to treat type II diabetes. We report here that sulfonylureas also function as chemical chaperones to rescue KATP channel trafficking defects caused by two SUR1 mutations, A116P and V187D, identified in patients with congenital hyperinsulinism. Sulfonylureas markedly increased cell surface expression of the A116P and V187D mutants by stabilizing the mutant SUR1 proteins and promoting their maturation. By contrast, diazoxide, a potassium channel opener that also binds SUR1, had no effect on surface expression of either mutant. Importantly, both mutant channels rescued to the cell surface have normal ATP, MgADP, and diazoxide sensitivities, demonstrating that SUR1 harboring either the A116P or the V187D mutation is capable of associating with Kir6.2 to form functional K ATP channels. Thus, sulfonylureas may be used to treat congenital hyperinsulinism caused by certain KATP channel trafficking mutations.

UR - http://www.scopus.com/inward/record.url?scp=1642565240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642565240&partnerID=8YFLogxK

U2 - 10.1074/jbc.M312810200

DO - 10.1074/jbc.M312810200

M3 - Article

VL - 279

SP - 11096

EP - 11105

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 12

ER -